Clinical Trial Update: Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine with or without capecitabine in advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED